➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
Mallinckrodt
Medtronic
Harvard Business School
Baxter

Last Updated: June 23, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for PPL-100


Email this page to a colleague

« Back to Dashboard

What is the drug development status for PPL-100?

PPL-100 is an investigational drug.

There have been 3 clinical trials for PPL-100. The most recent clinical trial was a Phase 2 trial, which was initiated on January 1st 2010.

The most common disease conditions in clinical trials are Ocular Hypertension, Hypertension, and Glaucoma, Open-Angle. The leading clinical trial sponsors are Mati Therapeutics Inc., Centre Hospitalier Universitaire, Amiens, and [disabled in preview].

Recent Clinical Trials for PPL-100
TitleSponsorPhase
A Dose Evaluation Study for the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle GlaucomaMati Therapeutics Inc.Phase 2
A Dose Evaluation Study of the Effect of Plug Placement on the Efficacy and Safety of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle GlaucomaMati Therapeutics Inc.Phase 2
Treatment of Primary Plasma Cell Leukaemia in Subjects Under the Age of 70Centre Hospitalier Universitaire, AmiensPhase 2

See all PPL-100 clinical trials

Clinical Trial Summary for PPL-100

Top disease conditions for PPL-100
Top clinical trial sponsors for PPL-100

See all PPL-100 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Moodys
Express Scripts
Johnson and Johnson
McKinsey
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.